Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022081700> ?p ?o ?g. }
- W2022081700 endingPage "140" @default.
- W2022081700 startingPage "130" @default.
- W2022081700 abstract "There is some evidence that treatment with interleukin-2 (IL-2) and interferon-alpha (IFNalpha) frequently induces depressive symptoms and activation of the inflammatory response system (IRS). There is evidence that major depression is accompanied by lowered serum activity of dipeptidyl peptidase IV (DPP IV; EC 3.4.14.5), a membrane-bound serine protease which catalyses the cleavage of some cytokines and neuro-active peptides and which modulates T cell activation and the production of cytokines, such as IL-2. This study was carried out to examine the effects of immunochemotherapy with IL-2 and IFNalpha, alone and together, in cancer patients on serum DPP IV activity in relation to changes in depressive symptoms and the IRS. The Montgomery and Asberg Rating Scale (MADRS), serum DPP IV activity, and the serum IL-6, and IL-2 receptor (IL-2R) concentrations were measured in 26 patients with metastatic cancers before and three and five days after treatment with IL-2 and IFNalpha, alone or together. Treatment with IL-2 with or without IFNalpha significantly suppressed serum DPP IV activity. The MADRS scores were significantly elevated by treatment with IL-2 with or without IFNalpha, but not IFNalpha alone. The immunochemotherapy-induced decreases in serum DPP IV were significantly and inversely correlated with the increases in the MADRS. Treatment with IL-2 alone or combined with IFNalpha also elevated serum IL-6 and IL-2R. There were significant and inverse correlations between the immuchemotherapy-induced decreases in serum DPP IV and the elevations in serum IL-6 or IL-2R. In conclusion, treatment with IL-2/IFNalpha decreases serum DPP IV activity within 3-5 days and the immunochemotherapy-induced decreases in serum DPP IV activity are significantly and inversely related to treatment-induced increases in severity of depression and signs of activation of the IRS." @default.
- W2022081700 created "2016-06-24" @default.
- W2022081700 creator A5019872290 @default.
- W2022081700 date "2001-02-01" @default.
- W2022081700 modified "2023-10-11" @default.
- W2022081700 title "Lowered Serum Dipeptidyl Peptidase IV Activity is Associated with Depressive Symptoms and Cytokine Production in Cancer Patients Receiving Interleukin-2-Based Immunotherapy" @default.
- W2022081700 cites W109431680 @default.
- W2022081700 cites W125967755 @default.
- W2022081700 cites W1562811233 @default.
- W2022081700 cites W1583655086 @default.
- W2022081700 cites W1752231260 @default.
- W2022081700 cites W175741237 @default.
- W2022081700 cites W1792389655 @default.
- W2022081700 cites W1828940258 @default.
- W2022081700 cites W1943202682 @default.
- W2022081700 cites W1966418185 @default.
- W2022081700 cites W1971051809 @default.
- W2022081700 cites W1972587126 @default.
- W2022081700 cites W1976762312 @default.
- W2022081700 cites W1985734566 @default.
- W2022081700 cites W1986891518 @default.
- W2022081700 cites W1989361804 @default.
- W2022081700 cites W1992023486 @default.
- W2022081700 cites W1992447913 @default.
- W2022081700 cites W1994199642 @default.
- W2022081700 cites W1996019229 @default.
- W2022081700 cites W2006104542 @default.
- W2022081700 cites W2020603363 @default.
- W2022081700 cites W2021723318 @default.
- W2022081700 cites W2024454400 @default.
- W2022081700 cites W2031908291 @default.
- W2022081700 cites W2034137314 @default.
- W2022081700 cites W2037484815 @default.
- W2022081700 cites W2040399742 @default.
- W2022081700 cites W2043477381 @default.
- W2022081700 cites W2051210308 @default.
- W2022081700 cites W2052884160 @default.
- W2022081700 cites W2053972082 @default.
- W2022081700 cites W2055223991 @default.
- W2022081700 cites W2055560891 @default.
- W2022081700 cites W2057559852 @default.
- W2022081700 cites W2058687438 @default.
- W2022081700 cites W2058978987 @default.
- W2022081700 cites W2061108828 @default.
- W2022081700 cites W2062142686 @default.
- W2022081700 cites W2065158430 @default.
- W2022081700 cites W2072640804 @default.
- W2022081700 cites W2079681415 @default.
- W2022081700 cites W2082162853 @default.
- W2022081700 cites W2086711207 @default.
- W2022081700 cites W2088890372 @default.
- W2022081700 cites W2093405089 @default.
- W2022081700 cites W2097970426 @default.
- W2022081700 cites W2110076708 @default.
- W2022081700 cites W2128394628 @default.
- W2022081700 cites W2131823335 @default.
- W2022081700 cites W2143625568 @default.
- W2022081700 cites W2151881464 @default.
- W2022081700 cites W2158811343 @default.
- W2022081700 cites W2161447126 @default.
- W2022081700 cites W2184811193 @default.
- W2022081700 cites W2206907718 @default.
- W2022081700 cites W2317554121 @default.
- W2022081700 cites W2319359283 @default.
- W2022081700 cites W2337277825 @default.
- W2022081700 cites W2341829866 @default.
- W2022081700 cites W2419611702 @default.
- W2022081700 cites W329201058 @default.
- W2022081700 cites W76693565 @default.
- W2022081700 cites W1992810574 @default.
- W2022081700 cites W2056930167 @default.
- W2022081700 doi "https://doi.org/10.1016/s0893-133x(00)00168-8" @default.
- W2022081700 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11120395" @default.
- W2022081700 hasPublicationYear "2001" @default.
- W2022081700 type Work @default.
- W2022081700 sameAs 2022081700 @default.
- W2022081700 citedByCount "49" @default.
- W2022081700 countsByYear W20220817002013 @default.
- W2022081700 countsByYear W20220817002014 @default.
- W2022081700 countsByYear W20220817002015 @default.
- W2022081700 countsByYear W20220817002017 @default.
- W2022081700 countsByYear W20220817002021 @default.
- W2022081700 countsByYear W20220817002022 @default.
- W2022081700 crossrefType "journal-article" @default.
- W2022081700 hasAuthorship W2022081700A5019872290 @default.
- W2022081700 hasBestOaLocation W20220817001 @default.
- W2022081700 hasConcept C121608353 @default.
- W2022081700 hasConcept C126322002 @default.
- W2022081700 hasConcept C134018914 @default.
- W2022081700 hasConcept C181199279 @default.
- W2022081700 hasConcept C185592680 @default.
- W2022081700 hasConcept C203014093 @default.
- W2022081700 hasConcept C2777701055 @default.
- W2022081700 hasConcept C2778690821 @default.
- W2022081700 hasConcept C2781469919 @default.
- W2022081700 hasConcept C55493867 @default.
- W2022081700 hasConcept C71924100 @default.
- W2022081700 hasConceptScore W2022081700C121608353 @default.